These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6420047)

  • 1. Effect on natural killer and antibody-dependent cellular cytotoxicity of adjuvant cytotoxic chemotherapy including melphalan in breast cancer.
    Mackay IR; Goodyear MD; Riglar C; Penschow J
    Cancer Immunol Immunother; 1983; 16(2):98-100. PubMed ID: 6420047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term preservation of antibody-dependent cellular cytotoxicity (ADCC) of natural killer cells amplified in vitro from the peripheral blood of breast cancer patients after chemotherapy.
    Clémenceau B; Gallot G; Vivien R; Gaschet J; Campone M; Vié H
    J Immunother; 2006; 29(1):53-60. PubMed ID: 16365600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on immunologic and other indices of adjuvant cytotoxic chemotherapy including melphalan in breast cancer.
    Mackay IR; Goodyear MD; Riglar C; Penschow J; Whittingham S; Russell IS; Kitchen PR; Collins JP
    Cancer; 1984 Jun; 53(12):2619-27. PubMed ID: 6609758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells
    Pham DH; Kim JS; Kim SK; Shin DJ; Uong NT; Hyun H; Yoon MS; Kang SJ; Ryu YJ; Cho JS; Yoon JH; Lee JS; Cho D; Lee SH; Park MH
    Anticancer Res; 2017 Oct; 37(10):5507-5513. PubMed ID: 28982863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu.
    Cooley S; Burns LJ; Repka T; Miller JS
    Exp Hematol; 1999 Oct; 27(10):1533-41. PubMed ID: 10517495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of chemotherapeutic and endocrine intervention on natural killer cell activity in human breast cancer.
    Brenner BG; Margolese RG
    Cancer; 1991 Aug; 68(3):482-8. PubMed ID: 2065267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel enhances antibody-dependent cell-mediated cytotoxicity of trastuzumab by rapid recruitment of natural killer cells in HER2-positive breast cancer.
    Miura D; Yoneyama K; Furuhata Y; Shimizu K
    J Nippon Med Sch; 2014; 81(4):211-20. PubMed ID: 25186575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant treatment of operable stomach cancer with polyadenylic.polyuridylic acid in addition to chemotherapeutic agents. Differential effect on natural killer cell and antibody-dependent cellular cytotoxicity.
    Youn JK; Kim BS; Min JS; Lee KS; Choi HJ; Lee YB; Lee DW; Koh EH; Kim KW; Lee KB
    Int J Immunopharmacol; 1987; 9(3):313-24. PubMed ID: 3610419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymostimulin increases natural cytotoxic activity in patients with breast cancer.
    Meneses G; Delgado MA; Perez-Machado MA; Prieto A; Alonso R; Carrion F; Lanzos E; Alvarez-Mon M
    Int J Immunopharmacol; 1997 Apr; 19(4):187-93. PubMed ID: 9373769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired natural killer cell lysis in breast cancer patients with high levels of psychological stress is associated with altered expression of killer immunoglobin-like receptors.
    Varker KA; Terrell CE; Welt M; Suleiman S; Thornton L; Andersen BL; Carson WE
    J Surg Res; 2007 May; 139(1):36-44. PubMed ID: 17292412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lenalidomide enhances antibody-dependent cellular cytotoxicity of solid tumor cells in vitro: influence of host immune and tumor markers.
    Wu L; Parton A; Lu L; Adams M; Schafer P; Bartlett JB
    Cancer Immunol Immunother; 2011 Jan; 60(1):61-73. PubMed ID: 20848094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer activity in patients with breast cancer.
    Bonilla F; Alvarez-Mon M; Merino F; Girón JA; Menéndez JL; Espana P; Durántez A
    Eur J Gynaecol Oncol; 1990; 11(2):103-9. PubMed ID: 2379508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of melphalan administration on the activity of natural killer and natural cytotoxic spleen cells of normal and tumor-bearing mice.
    Nahas F; Ophir R; Ben-Efraim S
    Immunol Lett; 1985; 10(6):333-7. PubMed ID: 4044020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-Year Follow-Up of Natural Killer Cell Activity in Multiple Myeloma Patients Treated With Adjuvant Lenalidomide Therapy.
    Besson L; Charrier E; Karlin L; Allatif O; Marçais A; Rouzaire P; Belmont L; Attal M; Lombard C; Salles G; Walzer T; Viel S
    Front Immunol; 2018; 9():704. PubMed ID: 29706958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of low-dose beta-interferon on natural killer cell activity in breast cancer patients subjected to chemotherapy.
    Tentori L; Fuggetta MP; D'Atri S; Aquino A; Nunziata C; Roselli M; Ballatore P; Bonmassar E; De Vecchis L
    Cancer Immunol Immunother; 1987; 24(1):86-91. PubMed ID: 3815421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel probably enhances cytotoxicity of natural killer cells against breast carcinoma cells by increasing perforin production.
    Kubo M; Morisaki T; Matsumoto K; Tasaki A; Yamanaka N; Nakashima H; Kuroki H; Nakamura K; Nakamura M; Katano M
    Cancer Immunol Immunother; 2005 May; 54(5):468-76. PubMed ID: 15592829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of naproxen therapy on natural killer cytotoxicity and antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus.
    Gonik B; Loo LS; Bigelow R; Kohl S
    J Reprod Med; 1984 Oct; 29(10):722-6. PubMed ID: 6512781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural immunity in breast cancer patients during neoadjuvant chemotherapy and after surgery.
    Beitsch P; Lotzová E; Hortobagyi G; Pollock R
    Surg Oncol; 1994 Aug; 3(4):211-9. PubMed ID: 7834112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-2 receptors, NK and LAK cytotoxicity of lymphocytes in breast carcinoma during prolonged thymopentin therapy.
    Mazzarino C; Nicosia A; Monte V; Petralia S; Garraffo C; Girlando A; Santoro S; Malaponte G
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):161-2. PubMed ID: 2128707
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of levamisole on human natural killer and killer cell activity and production of interferons.
    Liberati M; Borden EC; McBain JA; Raubertas R
    Immunopharmacology; 1982 Oct; 5(1):11-8. PubMed ID: 6182126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.